Westpac Banking Corp acquired a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 2,979 shares of the medical equipment provider’s stock, valued at approximately $1,211,000.
Several other hedge funds have also added to or reduced their stakes in the stock. Dogwood Wealth Management LLC raised its stake in shares of Intuitive Surgical by 178.3% in the third quarter. Dogwood Wealth Management LLC now owns 64 shares of the medical equipment provider’s stock valued at $26,000 after buying an additional 41 shares during the period. North Point Portfolio Managers Corp OH bought a new position in shares of Intuitive Surgical during the 3rd quarter worth $27,000. John Boyer Inc. bought a new position in shares of Intuitive Surgical during the 3rd quarter worth $27,000. Compass Wealth Management LLC purchased a new stake in Intuitive Surgical in the 3rd quarter worth about $29,000. Finally, Compass Financial Management LLC purchased a new stake in Intuitive Surgical in the 2nd quarter worth about $30,000. Institutional investors own 83.64% of the company’s stock.
Insider Buying and Selling at Intuitive Surgical
In other news, EVP Gary Loeb sold 400 shares of the company’s stock in a transaction dated Tuesday, November 10th. The stock was sold at an average price of $458.15, for a total transaction of $183,260.00. Following the sale, the executive vice president directly owned 6,236 shares in the company, valued at $2,857,023.40. This represents a 6.03% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Fredrik Widman sold 4,047 shares of the company’s stock in a transaction dated Friday, October 23rd. The shares were sold at an average price of $453.21, for a total value of $1,834,140.87. Following the sale, the vice president owned 1,026 shares in the company, valued at approximately $464,993.46. This represents a 79.78% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 39,363 shares of company stock worth $17,738,749. 0.60% of the stock is owned by corporate insiders.
Intuitive Surgical Stock Performance
Shares of NASDAQ ISRG opened at $399.06 on Friday. The stock has a market cap of $138.33 billion, a PE ratio of 48.25, a price-to-earnings-growth ratio of 3.02 and a beta of 1.45. Intuitive Surgical, Inc. has a fifty-two week low of $328.57 and a fifty-two week high of $603.88. The stock has a fifty day moving average of $423.51 and a 200-day moving average of $427.91.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last issued its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.65 by $0.35. The business had revenue of $3.05 billion for the quarter, compared to analysts’ expectations of $2.91 billion. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The firm’s quarterly revenue was up 21.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $2.40 EPS. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 9.37 EPS for the current year.
Analyst Upgrades and Downgrades
A number of brokerages recently issued reports on ISRG. Oppenheimer restated an “outperform” rating and issued a $500.00 price objective on shares of Intuitive Surgical in a research note on Wednesday, October 21st. BNP Paribas Exane upgraded shares of Intuitive Surgical to an “outperform” rating in a research report on Tuesday, July 28th. Royal Bank Of Canada reduced their target price on shares of Intuitive Surgical from $575.00 to $550.00 and set an “outperform” rating for the company in a research note on Wednesday, October 21st. Weiss Ratings reiterated a “hold (c)” rating on shares of Intuitive Surgical in a research note on Thursday, November 12th. Finally, Wall Street Zen raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Saturday, October 31st. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $495.90.
Check Out Our Latest Stock Analysis on ISRG
Latest Intuitive Surgical News
These are some of the ISRG news items that stood out recently:
- Neutral Sentiment: Options-market coverage notes activity that investors may want to watch, but provides no clear directional conclusion or confirmed catalyst. Options-market article
- Neutral Sentiment: An executive sold 46 shares under a pre-arranged Rule 10b5-1 plan. The transaction was small and scheduled in advance, so it is a limited signal about management’s outlook. Insider-sale report
- Negative Sentiment: ISRG was reported down 1.7% since its latest earnings report, suggesting the strong results have not yet translated into sustained share-price momentum. The article offers no fresh earnings-estimate change to clarify the potential for a rebound. Post-earnings performance article
Intuitive Surgical Company Profile
Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.
See Also
- Five stocks we like better than Intuitive Surgical
- MarketBeat Week in Review – 11/16 – 11/20
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
